Filing Flows › Stemtech (STEK) › Q1 2026 › vs Q4 2025
Stemtech (STEK) Q1 2026 vs Q4 2025 (quarter over quarter)
Stemtech's revenue rose $5K (+1%) from $458K in Q4 2025 to $463K in Q1 2026.
Stemtech, Q1 2026: revenue $463K (-47% year over year), operating margin -236.4%, net loss $1.3M, operating cash flow −$426K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $463K | $458K | $5K | +1% |
| Net loss | $1.3M | $1.5M | −$229K | -15% |
| Costs & expenses | $1.7M | $1.9M | −$225K | -12% |
| Operating costs | $1.6M | $1.3M | $235K | +18% |
| Interest & other, net | $159K | $618K | −$460K | -74% |
| Cost of revenue | $109K | $103K | $6K | +6% |
| Operating cash sources | $1.3M | $1.5M | −$229K | -15% |
| Depreciation & amortization | $42K | $42K | $8 | 0% |
| Share-based compensation | $108K | $111K | −$2K | -2% |
| Working capital & other | $677K | $1.5M | −$780K | -54% |
| Cash used in operations | $426K | −$127K | $553K | — |
| Net loss absorbed | $1.3M | $1.5M | −$229K | -15% |
Questions
How much did Stemtech's revenue grow quarter over quarter in Q1 2026?
Stemtech's revenue rose $5K (+1%) from $458K in Q4 2025 to $463K in Q1 2026.